DPTX3186

Asset

Sequesters beta-catenin into inactive depot condensates, inhibiting beta-catenin and Wnt-pathway activity.

Stage
Phase 1
Modality
Small molecule
Target
Not known
2
Indications
0
Trials
1
Developer

Indications

2

In the full profile

  • Owner and partners1
  • Competitors4

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets